Can an antioxidant supplement ease bladder troubles in older women?

NCT ID NCT06351683

Terminated Symptom relief Sponsor: Iman Al-Naggar, PhD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether MitoQ, an antioxidant supplement, could improve bladder symptoms like urgency and frequency in women aged 50 and older with metabolic syndrome. Twenty participants took either MitoQ or a placebo for 4 months, tracking their symptoms through questionnaires and bladder diaries. The trial was terminated early, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MitoQ (mitoquinol mesylate)
What this could lead to: If it works, this could point toward a simple supplement to help ease urgent or frequent urination in older women with metabolic syndrome.
What could go wrong: This was a very small pilot study (20 people) that was terminated early, so results are limited. It is too soon to know if MitoQ truly helps bladder symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Lower Urinary Tract Symptoms metabolic syndrome X overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOWER URINARY TRACT SYMPTOMS OVERACTIVE BLADDER SYNDROME

Contacts and locations

Locations

UConn Health

Farmington, Connecticut, 06030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.